1) When it dips under 4.00 2) When second IPO at $3.75. With a 29 million burn rate .... cash is disappearing fast. I have to admit ARRY has a nice pipeline, but they are in financial disaster. Not very good to do business like this. Instead of them focusing on currect drugs they keep announcing partnerships for drug discovery!!! Get your act together ARRY managment or leave like the last one.